Publicacións en colaboración con investigadores/as de Medical University of Vienna (8)

2024

  1. Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

    Advances in Therapy

2022

  1. European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on Retrograde Intrarenal Surgery for the Management of Renal Stones

    European Urology Focus, Vol. 8, Núm. 5, pp. 1461-1468

  2. Evidence-based Medicine: Perceptions, Attitudes, and Skills Among European Urology Residents

    European Urology Open Science, Vol. 45, pp. 44-49

  3. Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry

    European Urology Open Science, Vol. 45, pp. 12-22

2021

  1. Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis

    Frontiers in Surgery, Vol. 8

  2. Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry

    Targeted Oncology, Vol. 16, Núm. 3, pp. 357-367

2020

  1. Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry

    Targeted Oncology, Vol. 15, Núm. 3, pp. 301-315

2018

  1. A clinical evaluation of the new digital single-use flexible ureteroscope (UscopePU3022): An international prospective multicentered study

    Central European Journal of Urology, Vol. 71, Núm. 4, pp. 453-461